SlideShare a Scribd company logo
1 of 4
Duesberg Assignment
1 and 2) Following the advent of techniques such as Polymerase Chain Reaction (PCR), it is possible
to detect and analyse proviral DNA and viral RNA even in patients with AIDS. (Schutzbank and Smith,
1995) (Schwartz et al., 1991) (Vankerckhoven et al., 1994).
3) HIV-1 following studies has been found to be fairly species specific. In a bid to search for a suitable
nonhuman primate model system for studying HIV pathogenesis, HIV-1 was found to replicate badly
when using a macaque model (Humes et al., 2012). The study using Macaques were to investigate
the species specific amino acid sequences of the CD4+ Receptors. It was found that following infection
with HIV-1, the macaque CD4+ receptor was inefficient in mediating entry into cells. Another study
looking at species-specific co-factors essential for efficient replication, found that species-specific
genetic variations hindered the process of replication (Sherer et al., 2011). Both these studies show
good indication for species-specific hindrance for HIV-1 infection and therefore inability to go onto
cause AIDS, when using a model such as a chimpanzee.
Needle stick injuries have been well documented as causing HIV infection. Figures from the British
Journal of Anaesthesia, suggest 3 per 1000 needle stick injuries result in an HIV infection (Diprose et
al., 2000). Another good example for accidental infection is the case of the dentist David Acer.
Following an investigation by the Centre for Disease control, he was discovered to have infected
seven of his patients with HIV. Kimberly Bergalis one of his patient’s went on to develop AIDS 24
months after the initial infection. Another patient Barbara Webb now a prominent AIDS activist also
went on to develop AIDS (Cavender, 1992).
4) Infection by HIV is not the only reason for the death and loss of T-cells. There are biochemical
mechanisms in place which are capable of inducing spontaneous apoptosis in uninfected CD4+ and
CD8+ T-cells. Interaction of viral proteins such as Env with uninfected T-cell receptors such as CD4+
and the chemokine receptor CXCR4 has been found to induce apoptosis (Selliah and Finkel, 2001).
During clinical latency there is a daily viral production of 2 x 109 HIV particles, this is controlled by the
daily production of 2.6 x 109 new CD4+ cells. Lysed CD4+ cells release vast amounts of viral particles
which go on to infect more cells. It is in effect a continuing battle to produce enough T-cells to combat
the daily production of new virus. Eventually the levels of CD4+ cells simply cannot keep up and AIDS
will develop (Cann, 1997).
5) The immune system is able to cope with this initial infection with the virus, however it cannot
completely eradicate it, as it hides within non dividing memory T-cells and this acts as a reservoir.
During latency the HIV virus progressively kills off the CD4+ cells and continues to replicate within
lymph nodes due to their interaction with dendritic cells. Eventually CD4+ cells become unable to
sustain the immune system and AIDS will develop. HIV may be inactive at this point, but due to
depletion of the immune system by HIV, opportunistic infections are free to take hold of an immune
system which is essentially defenceless. The latency period is required for adequate depletion of the
immune system to allow for AIDS onset (Dimmock et al., 2007).
6) The initial immune response by interferon gamma produces flu like symptoms, CD4+ levels rise in
response to this and the virus colonises these cells, there is then a decrease in CD4+ levels during this
first infection period, after a while however the body replaces these CD4+ cells and viral numbers drop
as the immune system produces antibodies against GP120 (Flint et al., 2009). Variability in clinical
latency can be due to a number of factors including mutations in the viral proteins such as NEF. This
mutation results in the virus not being able to hide so efficiently from the immune system, resulting in
low viral numbers (Mwimanzi et al., 2011). AIDS does not progress immediately as the immune
system is able to keep the virus under control whilst CD4+ numbers are adequate.
7) HIV not only kills the CD4+ cells that are infected, cytolysis can occur in uninfected cells simply
when contact is made between these cells. This is partly due to the actions of the viral protein NEF
(Fujii et al., 1996).
Experiments conducted by Jeeninga et al (2008) to examine HIV-1 latency in actively dividing cells,
concluded that within the pathway SupT1 cell line, proviral latency was occurring. These results were
able to indicate that HIV-latency is a feature of both non-dividing cells as well as actively dividing cells.
8) HIV infection had strong connections to sexual behaviour and this varies amongst different
communities. Homosexuality is generally accepted in the United States and figures gathered in 2010
by the Centre for Disease control into the number of new HIV infections per year in the United States,
estimated that most-affected were gay white and black males (CDC, 2012). This is not the case in
many parts of Africa, where it is frowned upon and even illegal to be gay. Most of the people affected
in Africa are heterosexual. However, as committing sodomy is in some cases illegal, it is unlikely that
figures from Africa reflect or even include accurate numbers for HIV infection following homosexual
acts. High risk groups in Africa include female prostitutes and males partaking in heterosexual acts
with multiple female partners (Hunter, 1993).
The diseases associated with AIDS such as Kaposi’s sarcoma, Pneumocytosis and cytomegalovirus
are prevalent among all groups including, homosexuals, heterosexuals and intravenous drug users,
with the highest numbers being homosexuals (Lundgren et al., 1995) (Nasti et al., 2003).
In Africa endemic infectious diseases such as tuberculosis and malaria frequently infect HIV patients
and play a key role in fever, diarrhoea and malnutrition, thus resulting in “slim disease” (Anabwani and
Navario, 2005).
9) There is evidence to suggest HIV was present within humans further back than the 1980s. Using
evolutionary trees, Hillis (2000) was able to deduce a common ancestor. This date with a 95%
confidence interval was given as 1931.
The “cut theory” proposed by the virologist Crawford (2013) suggests that as early as 1900, hunters
within the Cameroon were infected when preparing infected bushmeat.
Reference List
ANABWANI, G. & NAVARIO, P. 2005. Nutrition and HIV/AIDS in Sub-Saharan Africa: an overview.
Nutrition, 21, 96-99.
CANN, A. 1997. Principles of molecular virology, London, Academic Press.
CAVENDER, J. W. 1992. AIDS in the health care setting: the congressional response to the Kimberly
Bergalis case. Georgia law review (Athens, Ga. : 1966), 26, 539-99.
CDC 2012. New HIV infections in the United States. In: CONTROL, C. F. D. (ed.). Atlanta: Centers for
Disease Control and Prevention.
CRAWFORD, D. H. 2013. Virus hunt : the search for the origin of HIV, Oxford, Oxford University
Press.
DIMMOCK, N. J., EASTON, A. J., LEPPARD, K. & NETLIBRARY, I. 2007. Introduction to modern
virology, Malden, MA, Blackwell Publishing.
DIPROSE, P., DEAKIN, C. D. & SMEDLEY, J. 2000. Ignorance of post-exposure prophylaxis
guidelines following HIV needlestick injury may increase the risk of seroconversion. British
Journal of Anaesthesia, 84, 767-770.
FLINT, S. J., ENQUIST, L. W., RACANIELLO, V. R. & SKALKA, A. M. 2009. Principles of Virology,
Washington, D. C, ASM Press.
FUJII, Y., OTAKE, K., TASHIRO, M. & ADACHI, A. 1996. In vitro cytocidal effects of human
immunodeficiency virus type 1 Nef on unprimed human CD4(+) T cells without MHC
restriction. Journal of General Virology, 77, 2943-2951.
HILLIS, D. M. 2000. Aids - Origins of HIV. Science, 288, 1757-+.
HUMES, D., EMERY, S., LAWS, E. & OVERBAUGH, J. 2012. A Species-Specific Amino Acid
Difference in the Macaque CD4 Receptor Restricts Replication by Global Circulating HIV-1
Variants Representing Viruses from Recent Infection. Journal of Virology, 86, 12472-12483.
HUNTER, D. J. 1993. Aids in sub-saharan africa - the epidemiology of heterosexual transmission and
the prospects for prevention. Epidemiology, 4, 63-72.
JEENINGA, R. E., WESTERHOUT, E. M., VAN GERVEN, M. L. & BERKHOUT, B. 2008. HIV-1
latency in actively dividing human T cell lines. Retrovirology, 5.
LUNDGREN, J. D., BARTON, S. E., LAZZARIN, A., DANNER, S., GOEBEL, F. D., PEHRSON, P.,
MULCAHY, F., KOSMIDIS, J., PEDERSEN, C. & PHILLIPS, A. N. 1995. Factors Associated
with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with
AIDS. Clinical Infectious Disease, 21, 106-113.
MWIMANZI, P., HASAN, Z., HASSAN, R., SUZU, S., TAKIGUCHI, M. & UENO, T. 2011. Effects of
naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's
functionality in primary macrophages. Retrovirology, 8.
NASTI, G. Y., BALLARDINI, G., STOPPINI, L., DI PERRI, G., MENA, M., TAVIO, M., VACCHER, E.,
MONFORTE, A. D. A. & TIRELLI, U. 2003. AIDS-Related Kaposi’s Sarcoma: Evaluation of
Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging
System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian
Cohort of Patients Naive From Antiretrovirals Journal of Clinical Oncology, 21, 2876-2882.
SCHUTZBANK, T. E. & SMITH, J. 1995. Detection of human-immunodeficiency-virus type-1 proviral
dna by pcr using an electrochemiluminescence-tagged probe. Journal of Clinical Microbiology,
33, 2036-2041.
SCHWARTZ, H. E., ULFELDER, K., SUNZERI, F. J., BUSCH, M. P. & BROWNLEE, R. G. 1991.
Analysis of dna restriction fragments and polymerase chain-reaction products towards
detection of the aids (HIV-1) virus in blood. Journal of Chromatography, 559, 267-283.
SELLIAH, N. & FINKEL, T. H. 2001. Biochemical mechanisms of HIV induced T cell apoptosis. Cell
Death and Differentiation, 8, 127-136.
SHERER, N. M., SWANSON, C. M., HUE, S., ROBERTS, R. G., BERGERON, J. R. C. & MALIM, M.
H. 2011. Evolution of a Species-Specific Determinant within Human CRM1 that Regulates the
Post-transcriptional Phases of HIV-1 Replication. Plos Pathogens, 7.
VANKERCKHOVEN, I., FRANSEN, K., PEETERS, M., DEBEENHOUWER, H., PIOT, P. &
VANDERGROEN, G. 1994. Quantification of human-immunodeficiency-virus in plasma by rna
pcr, viral culture, and p24 antigen-detection. Journal of Clinical Microbiology, 32, 1669-1673.

More Related Content

What's hot

Determination of Average HIV Replication in the Blood Plasma Using Truncated ...
Determination of Average HIV Replication in the Blood Plasma Using Truncated ...Determination of Average HIV Replication in the Blood Plasma Using Truncated ...
Determination of Average HIV Replication in the Blood Plasma Using Truncated ...paperpublications3
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...Dr. Aisha M Elbareg
 
Clinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIVClinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIVahmedicine
 
Challenges in risk assessment for viruses
Challenges in risk assessment for virusesChallenges in risk assessment for viruses
Challenges in risk assessment for virusesEFSA EU
 
Ethnic Differences in Genetic Immunity to Cancer_Crimson Publishers
Ethnic Differences in Genetic Immunity to Cancer_Crimson PublishersEthnic Differences in Genetic Immunity to Cancer_Crimson Publishers
Ethnic Differences in Genetic Immunity to Cancer_Crimson PublishersCrimsonpublishersCancer
 
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Alexander Decker
 
Livestock disease drivers, ecology and pathogen evolution
Livestock disease drivers, ecology and pathogen evolutionLivestock disease drivers, ecology and pathogen evolution
Livestock disease drivers, ecology and pathogen evolutionEFSA EU
 
JWeston-assignment-unit 9
JWeston-assignment-unit 9JWeston-assignment-unit 9
JWeston-assignment-unit 9Julia Weston
 
GDA - Superbugs and the role of diagnostics explained
GDA - Superbugs and the role of diagnostics explainedGDA - Superbugs and the role of diagnostics explained
GDA - Superbugs and the role of diagnostics explainedShweta Kulkarni Van Biesen
 
Superbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedSuperbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedeucomed
 
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...Meningitis Research Foundation
 
Pneumococcal Disease - Epidemiology & Resistance
Pneumococcal Disease - Epidemiology & ResistancePneumococcal Disease - Epidemiology & Resistance
Pneumococcal Disease - Epidemiology & ResistanceARPUTHA SELVARAJ A
 
Publications
PublicationsPublications
PublicationsYong Gao
 
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBC
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBCEdad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBC
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBCAlex Castañeda-Sabogal
 

What's hot (20)

Determination of Average HIV Replication in the Blood Plasma Using Truncated ...
Determination of Average HIV Replication in the Blood Plasma Using Truncated ...Determination of Average HIV Replication in the Blood Plasma Using Truncated ...
Determination of Average HIV Replication in the Blood Plasma Using Truncated ...
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
 
Vitamin d3 references
Vitamin d3 referencesVitamin d3 references
Vitamin d3 references
 
Clinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIVClinical Application of Stem Cells in HIV
Clinical Application of Stem Cells in HIV
 
Challenges in risk assessment for viruses
Challenges in risk assessment for virusesChallenges in risk assessment for viruses
Challenges in risk assessment for viruses
 
Ethnic Differences in Genetic Immunity to Cancer_Crimson Publishers
Ethnic Differences in Genetic Immunity to Cancer_Crimson PublishersEthnic Differences in Genetic Immunity to Cancer_Crimson Publishers
Ethnic Differences in Genetic Immunity to Cancer_Crimson Publishers
 
Bacteriology- Select gram ⊕ and gram ⊝ infections
Bacteriology- Select gram ⊕ and gram ⊝ infectionsBacteriology- Select gram ⊕ and gram ⊝ infections
Bacteriology- Select gram ⊕ and gram ⊝ infections
 
Carvalho 2008
Carvalho 2008Carvalho 2008
Carvalho 2008
 
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
Comparative seroprevalence and risk factors of toxoplasmosis among three subg...
 
Salmonella enterica serotype choleraesuis
Salmonella enterica serotype choleraesuisSalmonella enterica serotype choleraesuis
Salmonella enterica serotype choleraesuis
 
Livestock disease drivers, ecology and pathogen evolution
Livestock disease drivers, ecology and pathogen evolutionLivestock disease drivers, ecology and pathogen evolution
Livestock disease drivers, ecology and pathogen evolution
 
JWeston-assignment-unit 9
JWeston-assignment-unit 9JWeston-assignment-unit 9
JWeston-assignment-unit 9
 
GDA - Superbugs and the role of diagnostics explained
GDA - Superbugs and the role of diagnostics explainedGDA - Superbugs and the role of diagnostics explained
GDA - Superbugs and the role of diagnostics explained
 
Human genetics of tuberculosis
Human genetics of tuberculosisHuman genetics of tuberculosis
Human genetics of tuberculosis
 
Superbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explainedSuperbugs and the role of diagnostics explained
Superbugs and the role of diagnostics explained
 
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults...
 
Pneumococcal Disease - Epidemiology & Resistance
Pneumococcal Disease - Epidemiology & ResistancePneumococcal Disease - Epidemiology & Resistance
Pneumococcal Disease - Epidemiology & Resistance
 
Publications
PublicationsPublications
Publications
 
Colin Sutherland
Colin SutherlandColin Sutherland
Colin Sutherland
 
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBC
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBCEdad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBC
Edad sexo nutricion y recuperacion cd4 coinfeccion VIH/TBC
 

Viewers also liked

In research involving human participants as trial subjects or tissue
In research involving human participants as trial subjects or tissueIn research involving human participants as trial subjects or tissue
In research involving human participants as trial subjects or tissueCharlotte Litten
 
HSTM20031shortessay8466159
HSTM20031shortessay8466159HSTM20031shortessay8466159
HSTM20031shortessay8466159Charlotte Litten
 
LIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualLIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualCharlotte Litten
 
Fungal infection in hair
Fungal infection in hairFungal infection in hair
Fungal infection in hairVishal Kulkarni
 
Sexually transmitted infections
Sexually transmitted infectionsSexually transmitted infections
Sexually transmitted infectionsVishal Kulkarni
 
Bacterial vaccines
Bacterial vaccinesBacterial vaccines
Bacterial vaccinesTean Zaheer
 
Cellular immune response
Cellular immune responseCellular immune response
Cellular immune responseVishal Kulkarni
 
New generation vaccines
New generation vaccinesNew generation vaccines
New generation vaccinesMamta Singh
 
Recent advances in Vaccine_Dr. Mansij Biswas
Recent advances in Vaccine_Dr. Mansij BiswasRecent advances in Vaccine_Dr. Mansij Biswas
Recent advances in Vaccine_Dr. Mansij BiswasMansij Biswas
 
Antiviral chemotherapy
Antiviral chemotherapyAntiviral chemotherapy
Antiviral chemotherapyBruno Mmassy
 

Viewers also liked (20)

In research involving human participants as trial subjects or tissue
In research involving human participants as trial subjects or tissueIn research involving human participants as trial subjects or tissue
In research involving human participants as trial subjects or tissue
 
HSTM20031shortessay8466159
HSTM20031shortessay8466159HSTM20031shortessay8466159
HSTM20031shortessay8466159
 
Type VII secretion system
Type VII secretion systemType VII secretion system
Type VII secretion system
 
Type 6 Secretion Systems
Type 6 Secretion SystemsType 6 Secretion Systems
Type 6 Secretion Systems
 
Hospital infections
Hospital infectionsHospital infections
Hospital infections
 
LIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actualLIVE BACTERIA VACCINES actual
LIVE BACTERIA VACCINES actual
 
Fungal infection in hair
Fungal infection in hairFungal infection in hair
Fungal infection in hair
 
Slow virus diseases
Slow virus diseasesSlow virus diseases
Slow virus diseases
 
Halophilic vibrios
Halophilic vibriosHalophilic vibrios
Halophilic vibrios
 
Nonsporing anaerobes
Nonsporing anaerobesNonsporing anaerobes
Nonsporing anaerobes
 
Sexually transmitted infections
Sexually transmitted infectionsSexually transmitted infections
Sexually transmitted infections
 
Hacek
HacekHacek
Hacek
 
Human parasite vaccines
Human parasite vaccinesHuman parasite vaccines
Human parasite vaccines
 
Bacterial vaccines
Bacterial vaccinesBacterial vaccines
Bacterial vaccines
 
Cellular immune response
Cellular immune responseCellular immune response
Cellular immune response
 
Hepatitis b & c
Hepatitis b & cHepatitis b & c
Hepatitis b & c
 
New generation vaccines
New generation vaccinesNew generation vaccines
New generation vaccines
 
Recent advances in Vaccine_Dr. Mansij Biswas
Recent advances in Vaccine_Dr. Mansij BiswasRecent advances in Vaccine_Dr. Mansij Biswas
Recent advances in Vaccine_Dr. Mansij Biswas
 
Borrelia
BorreliaBorrelia
Borrelia
 
Antiviral chemotherapy
Antiviral chemotherapyAntiviral chemotherapy
Antiviral chemotherapy
 

Similar to Duesberg Assignment

AIDS PRESANTATION.pptx
AIDS PRESANTATION.pptxAIDS PRESANTATION.pptx
AIDS PRESANTATION.pptxMkindi Mkindi
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious DiseasesImhotep Virtual Medical School
 
Juice ImagesSuperStockLearning Objectives1. Compare t.docx
Juice ImagesSuperStockLearning Objectives1. Compare t.docxJuice ImagesSuperStockLearning Objectives1. Compare t.docx
Juice ImagesSuperStockLearning Objectives1. Compare t.docxpriestmanmable
 
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modelingmiguelhowella
 
Co relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patientsCo relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patientsRahul Nirmale
 
Chapter 18 AIDS, HIV Infection; Related Conditions
Chapter 18 AIDS, HIV Infection; Related Conditions Chapter 18 AIDS, HIV Infection; Related Conditions
Chapter 18 AIDS, HIV Infection; Related Conditions MeganSimpson27
 
Unit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxUnit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxBarentuShemsu
 
25. hiv infection and aids
25. hiv infection and aids25. hiv infection and aids
25. hiv infection and aidsAhmad Hamadi
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"StopTb Italia
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patientsجهاد الخريصي
 

Similar to Duesberg Assignment (20)

AIDS PRESANTATION.pptx
AIDS PRESANTATION.pptxAIDS PRESANTATION.pptx
AIDS PRESANTATION.pptx
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious Diseases
 
CD4 Cells Essay
CD4 Cells EssayCD4 Cells Essay
CD4 Cells Essay
 
Juice ImagesSuperStockLearning Objectives1. Compare t.docx
Juice ImagesSuperStockLearning Objectives1. Compare t.docxJuice ImagesSuperStockLearning Objectives1. Compare t.docx
Juice ImagesSuperStockLearning Objectives1. Compare t.docx
 
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
 
Hivaids, racing to the finish point
Hivaids, racing to the finish pointHivaids, racing to the finish point
Hivaids, racing to the finish point
 
HIV_Phylodynamics
HIV_PhylodynamicsHIV_Phylodynamics
HIV_Phylodynamics
 
Ghap hiv aids_handbook
Ghap hiv aids_handbookGhap hiv aids_handbook
Ghap hiv aids_handbook
 
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modeling
 
Co relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patientsCo relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patients
 
Chapter 18 AIDS, HIV Infection; Related Conditions
Chapter 18 AIDS, HIV Infection; Related Conditions Chapter 18 AIDS, HIV Infection; Related Conditions
Chapter 18 AIDS, HIV Infection; Related Conditions
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
HIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASEHIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASE
 
HIV AIDS paper
HIV AIDS paperHIV AIDS paper
HIV AIDS paper
 
Unit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptxUnit 16 HIV-AIDS (1).pptx
Unit 16 HIV-AIDS (1).pptx
 
25. hiv infection and aids
25. hiv infection and aids25. hiv infection and aids
25. hiv infection and aids
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
 
Aids epidemiology
Aids epidemiologyAids epidemiology
Aids epidemiology
 

Duesberg Assignment

  • 1. Duesberg Assignment 1 and 2) Following the advent of techniques such as Polymerase Chain Reaction (PCR), it is possible to detect and analyse proviral DNA and viral RNA even in patients with AIDS. (Schutzbank and Smith, 1995) (Schwartz et al., 1991) (Vankerckhoven et al., 1994). 3) HIV-1 following studies has been found to be fairly species specific. In a bid to search for a suitable nonhuman primate model system for studying HIV pathogenesis, HIV-1 was found to replicate badly when using a macaque model (Humes et al., 2012). The study using Macaques were to investigate the species specific amino acid sequences of the CD4+ Receptors. It was found that following infection with HIV-1, the macaque CD4+ receptor was inefficient in mediating entry into cells. Another study looking at species-specific co-factors essential for efficient replication, found that species-specific genetic variations hindered the process of replication (Sherer et al., 2011). Both these studies show good indication for species-specific hindrance for HIV-1 infection and therefore inability to go onto cause AIDS, when using a model such as a chimpanzee. Needle stick injuries have been well documented as causing HIV infection. Figures from the British Journal of Anaesthesia, suggest 3 per 1000 needle stick injuries result in an HIV infection (Diprose et al., 2000). Another good example for accidental infection is the case of the dentist David Acer. Following an investigation by the Centre for Disease control, he was discovered to have infected seven of his patients with HIV. Kimberly Bergalis one of his patient’s went on to develop AIDS 24 months after the initial infection. Another patient Barbara Webb now a prominent AIDS activist also went on to develop AIDS (Cavender, 1992). 4) Infection by HIV is not the only reason for the death and loss of T-cells. There are biochemical mechanisms in place which are capable of inducing spontaneous apoptosis in uninfected CD4+ and CD8+ T-cells. Interaction of viral proteins such as Env with uninfected T-cell receptors such as CD4+ and the chemokine receptor CXCR4 has been found to induce apoptosis (Selliah and Finkel, 2001). During clinical latency there is a daily viral production of 2 x 109 HIV particles, this is controlled by the daily production of 2.6 x 109 new CD4+ cells. Lysed CD4+ cells release vast amounts of viral particles which go on to infect more cells. It is in effect a continuing battle to produce enough T-cells to combat the daily production of new virus. Eventually the levels of CD4+ cells simply cannot keep up and AIDS will develop (Cann, 1997). 5) The immune system is able to cope with this initial infection with the virus, however it cannot completely eradicate it, as it hides within non dividing memory T-cells and this acts as a reservoir. During latency the HIV virus progressively kills off the CD4+ cells and continues to replicate within lymph nodes due to their interaction with dendritic cells. Eventually CD4+ cells become unable to sustain the immune system and AIDS will develop. HIV may be inactive at this point, but due to depletion of the immune system by HIV, opportunistic infections are free to take hold of an immune
  • 2. system which is essentially defenceless. The latency period is required for adequate depletion of the immune system to allow for AIDS onset (Dimmock et al., 2007). 6) The initial immune response by interferon gamma produces flu like symptoms, CD4+ levels rise in response to this and the virus colonises these cells, there is then a decrease in CD4+ levels during this first infection period, after a while however the body replaces these CD4+ cells and viral numbers drop as the immune system produces antibodies against GP120 (Flint et al., 2009). Variability in clinical latency can be due to a number of factors including mutations in the viral proteins such as NEF. This mutation results in the virus not being able to hide so efficiently from the immune system, resulting in low viral numbers (Mwimanzi et al., 2011). AIDS does not progress immediately as the immune system is able to keep the virus under control whilst CD4+ numbers are adequate. 7) HIV not only kills the CD4+ cells that are infected, cytolysis can occur in uninfected cells simply when contact is made between these cells. This is partly due to the actions of the viral protein NEF (Fujii et al., 1996). Experiments conducted by Jeeninga et al (2008) to examine HIV-1 latency in actively dividing cells, concluded that within the pathway SupT1 cell line, proviral latency was occurring. These results were able to indicate that HIV-latency is a feature of both non-dividing cells as well as actively dividing cells. 8) HIV infection had strong connections to sexual behaviour and this varies amongst different communities. Homosexuality is generally accepted in the United States and figures gathered in 2010 by the Centre for Disease control into the number of new HIV infections per year in the United States, estimated that most-affected were gay white and black males (CDC, 2012). This is not the case in many parts of Africa, where it is frowned upon and even illegal to be gay. Most of the people affected in Africa are heterosexual. However, as committing sodomy is in some cases illegal, it is unlikely that figures from Africa reflect or even include accurate numbers for HIV infection following homosexual acts. High risk groups in Africa include female prostitutes and males partaking in heterosexual acts with multiple female partners (Hunter, 1993). The diseases associated with AIDS such as Kaposi’s sarcoma, Pneumocytosis and cytomegalovirus are prevalent among all groups including, homosexuals, heterosexuals and intravenous drug users, with the highest numbers being homosexuals (Lundgren et al., 1995) (Nasti et al., 2003). In Africa endemic infectious diseases such as tuberculosis and malaria frequently infect HIV patients and play a key role in fever, diarrhoea and malnutrition, thus resulting in “slim disease” (Anabwani and Navario, 2005). 9) There is evidence to suggest HIV was present within humans further back than the 1980s. Using evolutionary trees, Hillis (2000) was able to deduce a common ancestor. This date with a 95% confidence interval was given as 1931. The “cut theory” proposed by the virologist Crawford (2013) suggests that as early as 1900, hunters within the Cameroon were infected when preparing infected bushmeat.
  • 3. Reference List ANABWANI, G. & NAVARIO, P. 2005. Nutrition and HIV/AIDS in Sub-Saharan Africa: an overview. Nutrition, 21, 96-99. CANN, A. 1997. Principles of molecular virology, London, Academic Press. CAVENDER, J. W. 1992. AIDS in the health care setting: the congressional response to the Kimberly Bergalis case. Georgia law review (Athens, Ga. : 1966), 26, 539-99. CDC 2012. New HIV infections in the United States. In: CONTROL, C. F. D. (ed.). Atlanta: Centers for Disease Control and Prevention. CRAWFORD, D. H. 2013. Virus hunt : the search for the origin of HIV, Oxford, Oxford University Press. DIMMOCK, N. J., EASTON, A. J., LEPPARD, K. & NETLIBRARY, I. 2007. Introduction to modern virology, Malden, MA, Blackwell Publishing. DIPROSE, P., DEAKIN, C. D. & SMEDLEY, J. 2000. Ignorance of post-exposure prophylaxis guidelines following HIV needlestick injury may increase the risk of seroconversion. British Journal of Anaesthesia, 84, 767-770. FLINT, S. J., ENQUIST, L. W., RACANIELLO, V. R. & SKALKA, A. M. 2009. Principles of Virology, Washington, D. C, ASM Press. FUJII, Y., OTAKE, K., TASHIRO, M. & ADACHI, A. 1996. In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4(+) T cells without MHC restriction. Journal of General Virology, 77, 2943-2951. HILLIS, D. M. 2000. Aids - Origins of HIV. Science, 288, 1757-+. HUMES, D., EMERY, S., LAWS, E. & OVERBAUGH, J. 2012. A Species-Specific Amino Acid Difference in the Macaque CD4 Receptor Restricts Replication by Global Circulating HIV-1 Variants Representing Viruses from Recent Infection. Journal of Virology, 86, 12472-12483. HUNTER, D. J. 1993. Aids in sub-saharan africa - the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology, 4, 63-72. JEENINGA, R. E., WESTERHOUT, E. M., VAN GERVEN, M. L. & BERKHOUT, B. 2008. HIV-1 latency in actively dividing human T cell lines. Retrovirology, 5. LUNDGREN, J. D., BARTON, S. E., LAZZARIN, A., DANNER, S., GOEBEL, F. D., PEHRSON, P., MULCAHY, F., KOSMIDIS, J., PEDERSEN, C. & PHILLIPS, A. N. 1995. Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS. Clinical Infectious Disease, 21, 106-113. MWIMANZI, P., HASAN, Z., HASSAN, R., SUZU, S., TAKIGUCHI, M. & UENO, T. 2011. Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology, 8. NASTI, G. Y., BALLARDINI, G., STOPPINI, L., DI PERRI, G., MENA, M., TAVIO, M., VACCHER, E., MONFORTE, A. D. A. & TIRELLI, U. 2003. AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging
  • 4. System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals Journal of Clinical Oncology, 21, 2876-2882. SCHUTZBANK, T. E. & SMITH, J. 1995. Detection of human-immunodeficiency-virus type-1 proviral dna by pcr using an electrochemiluminescence-tagged probe. Journal of Clinical Microbiology, 33, 2036-2041. SCHWARTZ, H. E., ULFELDER, K., SUNZERI, F. J., BUSCH, M. P. & BROWNLEE, R. G. 1991. Analysis of dna restriction fragments and polymerase chain-reaction products towards detection of the aids (HIV-1) virus in blood. Journal of Chromatography, 559, 267-283. SELLIAH, N. & FINKEL, T. H. 2001. Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death and Differentiation, 8, 127-136. SHERER, N. M., SWANSON, C. M., HUE, S., ROBERTS, R. G., BERGERON, J. R. C. & MALIM, M. H. 2011. Evolution of a Species-Specific Determinant within Human CRM1 that Regulates the Post-transcriptional Phases of HIV-1 Replication. Plos Pathogens, 7. VANKERCKHOVEN, I., FRANSEN, K., PEETERS, M., DEBEENHOUWER, H., PIOT, P. & VANDERGROEN, G. 1994. Quantification of human-immunodeficiency-virus in plasma by rna pcr, viral culture, and p24 antigen-detection. Journal of Clinical Microbiology, 32, 1669-1673.